Using single-cell epigenomic profiling of immune cells from 110 individuals, researchers show that genetic variation and ...
Group results In 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 61.5 billion due to strong demand for pharmaceutical products and diagnostic solutions. The appreciation of the Swiss franc ...
Group sales grew by 7%1 at constant exchange rates (CER; 2% in CHF), driven by strong demand for medicines and diagnostic solutions.Sales in the fourth quarter increased by 8%, reflecting the positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results